Badalzadeh Reza, Tabatabaei Seyed Mahmoud, Mohammadi Mustafa, Khaki Arash, Mohammadnezhad Dariush
Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Iran J Basic Med Sci. 2017 Oct;20(10):1079-1087. doi: 10.22038/IJBMS.2017.9444.
Chronic diabetes impedes cardioprotection in reperfusion injury and hence protecting the diabetic heart would have important outcomes. In this study, we evaluated whether combined postconditioning with ischemia and cyclosporine-A can restore oxidative stress and histopathological changes in reperfusion injury of the diabetic myocardium.
Streptozocin-induced diabetic hearts and nondiabetic controls in eight subgroups (with or without receiving ischemic-postconditioning (IPostC), cyclosporine-A, an inhibitor of mitochondrial permeability transition, or both of them) suffered from 30 min regional ischemia followed by 45 min reperfusion on an isolated-heart Langendorff system. The levels of lactate dehydrogenase (LDH) in the coronary effluent, and the levels of oxidative stress markers including 8-isoprostane, superoxide dismutase (SOD), glutathione peroxidase (GPX), and total antioxidant capacity (TAC) in myocardial supernatant prepared from the ischemic zone were measured using specific kits, spectrophotometrically. Histopathological studies were performed -eosin staining method.
Administration of IPostC and cyclosporine-A (alone or together) in nondiabetic hearts potentially reduced the severity of histological changes and level of LDH release as compared with untreated-controls (P<0.05). of any procedures in diabetic hearts did not show significant cardioprotective effects (P>0.1). However, the combined postconditioning with ischemia and CsA exerted significant protective effects in diabetic hearts (P<0.05).
By augmenting the protective effects of IPostC and CsA through their combined application, reperfusion injury and related oxidative stress are reduced in diabetic hearts similar to non-diabetics.
慢性糖尿病会阻碍再灌注损伤中的心脏保护作用,因此保护糖尿病心脏将产生重要的结果。在本研究中,我们评估了缺血后处理与环孢素A联合应用是否能恢复糖尿病心肌再灌注损伤中的氧化应激和组织病理学变化。
将链脲佐菌素诱导的糖尿病心脏和非糖尿病对照分为八个亚组(接受或不接受缺血后处理(IPostC)、环孢素A(一种线粒体通透性转换抑制剂)或两者),在离体心脏Langendorff系统上进行30分钟的局部缺血,随后进行45分钟的再灌注。使用特定试剂盒通过分光光度法测量冠状动脉流出液中乳酸脱氢酶(LDH)的水平,以及从缺血区制备的心肌上清液中氧化应激标志物的水平,包括8-异前列腺素、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GPX)和总抗氧化能力(TAC)。采用苏木精-伊红染色法进行组织病理学研究。
与未处理的对照组相比,非糖尿病心脏单独或联合给予IPostC和环孢素A可潜在降低组织学变化的严重程度和LDH释放水平(P<0.05)。糖尿病心脏的任何处理均未显示出显著的心脏保护作用(P>0.1)。然而,缺血与环孢素A联合后处理对糖尿病心脏具有显著的保护作用(P<0.05)。
通过联合应用增强IPostC和环孢素A的保护作用,糖尿病心脏中的再灌注损伤和相关氧化应激与非糖尿病心脏相似,均得以减轻。